Pfizer Inc (PFE) Stock Forecast
US · Healthcare
Current price
$23.67
Market cap
$134.91B
Mean price target
$29.15
Implied upside
23.2%
Key takeaways
- Analysts rate Pfizer Inc a “Buy”, with a mean price target of $29.15 — about 23.2% upside from the current $23.67, based on 27 analysts.
- PFE is trading near its 52-week low, at 10% of the $23.11–$28.75 band.
Analyst consensus
| Consensus rating | Buy |
|---|---|
| Number of analysts | 27 |
| Mean target | $29.15 |
| High target | $36.00 |
| Low target | $24.00 |
| Rating split (SB / B / H / S / SS) | 2 / 8 / 15 / 1 / 2 |
Price & trading
| Current price | $23.67 |
|---|---|
| Previous close | $24.04 |
| 52-week high | $28.75 |
| 52-week low | $23.11 |
| 50-day average | $26.09 |
| Beta | 0.29 |
See the full PFE breakdown on Luminoso
Valuation, profitability, efficiency, leverage & earnings-quality metrics — updated daily.
Start free — 2 months on usFrequently asked questions
- What is the current Pfizer Inc (PFE) share price?
- Pfizer Inc last traded at $23.67 with a market capitalisation of about $134.9B.
- What is the analyst price target for PFE?
- The mean analyst price target for Pfizer Inc is $29.15, roughly 23.2% above the latest price. The current consensus rating is “Buy”.
- Where can I see Pfizer Inc's full financial metrics?
- Luminoso tracks PFE's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.
More stocks
Browse all companies covered by Luminoso →
Last updated 25 Jun 2026.
Data is provided for informational purposes only and is not investment advice. Figures are cached and refreshed daily; they may differ from real-time quotes.